Not Yet Recruiting
FLASH Pilot Phase 1 Safety Study
NCT07608549
- Conditions
- Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
694 public trials
105 recruiting studies
Lymphoma, T-Cell trial results
Not Yet Recruiting
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
NCT05728879
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Dermatology CTU Chicago, Illinois, United States
Not Yet Recruiting
Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
NCT07554482
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Beijing Tongren Hospital, Capital Medical University Beijing, China
Not Yet Recruiting
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
NCT07542912
- Conditions
- Adverse Event, Complete Remission Rate， CRR, Duration of Response, +8 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
Not Yet Recruiting
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
NCT07535710
- Conditions
- Cutaneous T Cell Lymphoma (CTCL), Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, +16 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China
- Ruijin Hospital Wuxi Branch Wuxi, China
Not Yet Recruiting
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
NCT07535762
- Conditions
- Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Shanghai, China
- Ruijin Hospital Wuxi Branch Wuxi, China
Not Yet Recruiting
A Study of VG712 in Patients With Mycosis Fungoides
NCT07529405
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Not Yet Recruiting
BV-CHP Real-life and Biological Evidences in Patients With sALCL
NCT07467317
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- A.O.R.N. S. Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy
- I.R.C.C.S. Centro di Riferimento Oncologico - S.O.C. Oncologia medica e dei tumori immuno-correlati Aviano, Italy
- I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- A.S.S.T Papa Giovanni XXIII - S.C. Ematologia Bergamo, Italy
Not Yet Recruiting
Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)
NCT07477769
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +21 more
- Locations
-
Not specified
Not Yet Recruiting
Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL
NCT07457177
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
Not specified